Neuland Laboratories to host analysts at Goldman Sachs CDMO day

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Neuland Laboratories to attend Goldman Sachs Global Healthcare CDMO Day
  • Event scheduled for September 23-25, 2026 in Singapore
  • Management to hold group and one-on-one investor meetings
  • Disclosure made under SEBI Regulation 30 on September 16, 2026
powered bylight_fuzz_icon
51108690

*this image is generated using AI for illustrative purposes only.

Neuland Laboratories will participate in the Goldman Sachs Global Healthcare CDMO Day in Singapore from September 23-25, 2026. The company's management team is scheduled to hold both group and one-on-one meetings with institutional investors and analysts during the event.

Meeting Details

The engagement forms part of Neuland's investor relations calendar for the quarter. The company disclosed the schedule under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Date Event Location Format
September 23-25, 2026 Goldman Sachs Global Healthcare CDMO Day Singapore Group and One-on-One

Sarada Bhamidipati, Company Secretary, signed the intimation filed with the Bombay Stock Exchange and National Stock Exchange on September 16, 2026. The company noted that the schedule and participant list remain subject to change based on exigencies involving participants or the company.

Historical Stock Returns for Neuland Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.77%-4.03%-3.47%+86.10%+41.37%+1,314.33%

How might Neuland Laboratories' presentation at the Goldman Sachs CDMO Day influence its valuation multiples relative to global peers in the coming quarter?

What specific strategic initiatives or capacity expansion plans is Neuland likely to highlight to attract long-term institutional capital during these meetings?

Could increased engagement with global investors signal Neuland's intent to pursue cross-border M&A or joint ventures in the CDMO sector?

Neuland Laboratories to host analyst and investor meeting on September 23

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Neuland Laboratories has scheduled a meeting with analysts and investors on September 23.
  • The announcement was made by the company to inform stakeholders of the upcoming engagement.
powered bylight_fuzz_icon
51102998

*this image is generated using AI for illustrative purposes only.

Neuland Laboratories has scheduled a meeting with analysts and investors on September 23.

Meeting details

The company has announced it will host an interaction with analysts and investors on September 23. Such meetings typically serve as a platform for the company's management to engage directly with the investment community.

Parameter Details
Event Analyst and investor meeting
Date September 23
Hosted by Neuland Laboratories

Neuland Laboratories has informed stakeholders of this scheduled engagement, which provides analysts and investors an opportunity to interact with the company.

Historical Stock Returns for Neuland Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.77%-4.03%-3.47%+86.10%+41.37%+1,314.33%
Disclaimer: This article is AI-generated using data from LiveSquawk. ScanX is not liable for any inaccuracies.

What specific strategic updates or financial guidance is Neuland Laboratories expected to unveil during the September 23 meeting?

How might the insights shared with analysts impact Neuland Laboratories' stock valuation in the immediate weeks following the event?

Are there indications that this meeting coincides with any upcoming product launches, regulatory approvals, or partnership announcements?

More News on Neuland Laboratories

1 Year Returns:+41.37%